Screener
Pfizer PFE Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The source filing: Pfizer’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000078003-26-000054
| (MILLIONS) | March 29, 2026 / Gross Carrying Amount | March 29, 2026 / Accumulated Amortization | March 29, 2026 / Identifiable Intangible Assets, Net | December 31, 2025 / Gross Carrying Amount | December 31, 2025 / Accumulated Amortization | December 31, 2025 / Identifiable Intangible Assets, Net |
|---|---|---|---|---|---|---|
| Developed technology rights(a) | $101,396 | $(71,491) | $29,905 | $100,630 | $(70,172) | $30,458 |
| Brands | 1,035 | (1,035) | — | 1,035 | (1,035) | — |
| Licensing agreements and other | 2,350 | (1,336) | 1,013 | 2,341 | (1,289) | 1,052 |
| 104,780 | (73,862) | 30,918 | 104,006 | (72,496) | 31,510 | |
| Indefinite-lived intangible assets | ||||||
| IPR&D(a) | 21,180 | 21,180 | 21,760 | 21,760 | ||
| Licensing agreements and other | 460 | 460 | 460 | 460 | ||
| 21,641 | 21,641 | 22,221 | 22,221 |
Item 1.
FAQ
- What is Pfizer's finite-lived intangible assets, accumulated amortization?
- Pfizer (PFE) reported finite-lived intangible assets, accumulated amortization of $73.86B in Q1 2026.
- How has Pfizer's finite-lived intangible assets, accumulated amortization changed year-over-year?
- Pfizer's finite-lived intangible assets, accumulated amortization increased by 7.4% year-over-year, from $68.78B to $73.86B.
- What is the long-term trend for Pfizer's finite-lived intangible assets, accumulated amortization?
- Over 5 years (2020 to 2025), Pfizer's finite-lived intangible assets, accumulated amortization has grown at a 6.5% compound annual growth rate (CAGR), from $52.86B to $72.5B.
Ask your AI about Pfizer's finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude